Home About Us Product BPH Overview Opportunity Contact Us  
 
 
 
 

PRODUCT > DEVELOPMENT STATUS

In a short period of time and with limited resources, ProArc has succeeded in completing the development of a prototype for clinical trials. ProArc’s pre-clinical validation includes successful trials with animals and human cadavers, performed by two experienced urologists: Prof. Ilan Leibovitch from Israel, and Prof. Egils Vejaters from Latvia.

Earlier this year, the Company has completed its First-In-Man (FIM) study, with extremely promising safety and efficacy six-months follow-up data.


X-ray image, three months post-procedure - a significant expansion of a canine’s urethra, as a result of the ClearRing procedure.


ProArc Medical is scheduled to initiate a multi-center study in 4Q2015. This clinical trial would provide robust safety and efficacy data, and will support the Company's efforts toward securing a regulatory approval in Europe.

 
 
  Home | About Us | Products | Opportunity | Contact Us